Matches in Nanopublications for { <http://bio2rdf.org/drugbank_resource:DB00582_DB01101> ?p ?o ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- drugbank_resource:DB00582_DB01101 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00582_DB01101 label "DDI between Voriconazole and Capecitabine - Capecitabine, a strong CYP2C9 inhibitor, may increase the serum concentration of voriconazole by decreasing its metabolism. Monitor for changes in the therapeutic and adverse effects of voriconazole if capecitabine is initiated, discontinued or dose changed. [drugbank_resource:DB00582_DB01101]" assertion.
- drugbank_resource:DB00582_DB01101 identifier "drugbank_resource:DB00582_DB01101" assertion.
- drugbank_resource:DB00582_DB01101 title "DDI between Voriconazole and Capecitabine - Capecitabine, a strong CYP2C9 inhibitor, may increase the serum concentration of voriconazole by decreasing its metabolism. Monitor for changes in the therapeutic and adverse effects of voriconazole if capecitabine is initiated, discontinued or dose changed." assertion.